Author: Tanya Laidlaw, MD

In a study conducted here at Brigham and Women’s, researcher Cahill et al. sought to explore the longitudinal changes in biomarkers of patient’s with AERD who take high-dose aspirin therapy. A total of 57 patients were enrolled, 42 with AERD…

The AERD Center is proud to announce the addition of Dr. Lily Li to the clinical staff at Brigham Allergy! Dr. Li will be running an allergy clinic for patients with a history of aspirin & NSAID reactions. She attended…

Aspirin-Exacerbated Respiratory Disease This manuscript from the Scripps AERD Center in California gives an all-encompassing picture of Aspirin-Exacerbated Respiratory Disease. In this comprehensive review, Drs. White and Stevenson aim to educate readers on the history of AERD, classical reactions to…

Depression symptoms and quality of life among individuals with Aspirin-Exacerbated Respiratory Disease This study, directed by Dr. Elina Jerschow’s group in New York, was the first to examine levels of depression and disease- and asthma-related quality of life among patients…

Eosinophilia-Associated Coronary Artery Vasospasm in Patients with Aspirin-Exacerbated Respiratory Disease Some patients with AERD and increased eosinophil cells in their blood have reported angina-like chest pain that occurs at rest, responds to systemic corticosteroid/prednisone therapy, and is presumed to be…

Alcohol-induced respiratory symptoms improve after aspirin desensitization in patients with aspirin-exacerbated respiratory disease This study, directed by Dr. John Bosso and the research team at the University of Pennsylvania, suggests that aspirin desensitization and treatment with high-dose daily aspirin may…

Zyflo details Zyflo CR is an asthma medication that inhibits the production of leukotrienes, inflammatory molecules that contribute to airway inflammation in patients with AERD. Zyflo CR is typically prescribed as two 600 mg pills that are taken twice a…